MARY KING: Open Payments
NPI 1477042745 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 39 payments from 14 companies in 2025. Trend: 2023 $66 · 2024 $433 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $180 |
| PFIZER INC. | 6 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| United Therapeutics Corporation | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| ConvaTec Inc. | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $25 |
Products named: Kerendia, JARDIANCE, ELIQUIS, VYNDAQEL, CAMZYOS, Attruby, Repatha, LEQVIO.
Industry payments across AL — which companies pay providers there.
